Dianthus Therapeutics (DNTH) Total Current Liabilities (2017 - 2025)
Historic Total Current Liabilities for Dianthus Therapeutics (DNTH) over the last 8 years, with Q3 2025 value amounting to $23.9 million.
- Dianthus Therapeutics' Total Current Liabilities rose 5184.6% to $23.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.9 million, marking a year-over-year increase of 5184.6%. This contributed to the annual value of $18.5 million for FY2024, which is 9158.97% up from last year.
- According to the latest figures from Q3 2025, Dianthus Therapeutics' Total Current Liabilities is $23.9 million, which was up 5184.6% from $20.1 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Total Current Liabilities registered a high of $23.9 million during Q3 2025, and its lowest value of $4.0 million during Q2 2023.
- For the 4-year period, Dianthus Therapeutics' Total Current Liabilities averaged around $12.9 million, with its median value being $12.9 million (2022).
- Per our database at Business Quant, Dianthus Therapeutics' Total Current Liabilities plummeted by 6416.13% in 2023 and then soared by 14861.18% in 2024.
- Over the past 4 years, Dianthus Therapeutics' Total Current Liabilities (Quarter) stood at $8.2 million in 2022, then grew by 17.09% to $9.6 million in 2023, then soared by 91.59% to $18.5 million in 2024, then grew by 29.28% to $23.9 million in 2025.
- Its last three reported values are $23.9 million in Q3 2025, $20.1 million for Q2 2025, and $17.0 million during Q1 2025.